Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
Status:
Not yet recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
The study will include 444 pregnant patients undergoing cesarean section in Kasr Al Aini.
Following a proper medical history taking, examination will be done, investigations including
laboratory tests and obstetric ultrasound will be done.
Then, the patients will be divided into 4 groups, receiving Oxytocin only (Group 1), Oxytocin
+ Tranexamic acid (Group 2), Oxtytocin and Misoprostol (Group 3) or Oxytocin and Carbetocin
(Group 4) followed by collection of necessary data.